Wall Street is moving some bets on COVID-19 vaccines to large pharmaceutical companies with robust manufacturing capabilities, signaling that a love affair with small biotech firms might be ending after the sector’s best quarter in almost 20 years.
Read more: https://www.reuters.com/article/us-health-coronavirus-stocks-idUSKBN24333M?source=Snapzu
No comments:
Post a Comment